![Sorafenib- and anthracycline-based therapies for patients with desmoid tumors – ACS Journal Cancer](https://oncodaily.com/pub/uploads/2025/02/Philippos-Apolinario-Costa-1280x720.jpg)
Philippos Apolinario Costa/X
Feb 10, 2025, 11:22
Sorafenib- and anthracycline-based therapies for patients with desmoid tumors – ACS Journal Cancer
ACS Journal Cancer shared a post on X about a paper by Philippos Apolinario Costa et al. published in Cancer Journal:
“Original work by Philippos Apolinario Costa et al. examines sorafenib- and anthracycline-based therapies for patients with desmoid tumors.
Read the study and an accompanying editorial from Dr. Bernd Kasper.”
“Sorafenib or anthracycline-based chemotherapy for progressive desmoid tumors”
Authors: Philippos Apolinario Costa, Arshia Arora, Yannelys Fernandez, Hari Deshpande, Jonathan Trent et al.
More posts featuring ACS Journal Cancer.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 10, 2025, 11:18
Feb 10, 2025, 10:52
Feb 10, 2025, 10:45
Feb 10, 2025, 10:04